JCI Editorial Board
potential first-tier conflicts of interest

Updated March 3, 2025

Go to the JCI's conflict-of-interest policy

 

AbbVie (S.E. Quaggin)

AccureX (D. Krainc)

Alnylam (A.B. Heimberger)

Aplexis Inc. (P. Ji)

Arvinas (M. Hussain)

AstraZeneca (M. Hussain)

Bayer (M. Hussain)

Biofluid Technology (E.M. McNally)

Biohaven Pharmaceuticals Inc. (A.L. George Jr.)

BioMed Central (H. Perlman)

Borealis Biosciences (B.D. Humphreys)

Calidi Biotherapeutics (M.S. Lesniak)

Carbiogene Therapeutics Co. Ltd. (Y. Yang)

Caris Life Sciences (A.B. Heimberger)

Cell IDx (E.M. McNally)

Chinook Therapeutics (Novartis) (B.D. Humphreys)

Cytokinetics (E.M. McNally)

Gateway Biome (E.B. Chang)

Ikaika Therapeutics (E.M. McNally)

Inomagen Therapeutics (R.K. Arora)

Ionis (J. Bass)

Lakeside Discovery (E.M. McNally, A. Shilatifard)

Leal Therapeutics (D. Krainc)

Leducq Foundation (H. Ardehali)

Lung Healing Technologies (A. Bharat)

Lung IQ LLC (A. Bharat)

Mannin Research Inc. (S.E. Quaggin)

Medtronic (J. Bass)

Michael J. Fox Foundation (D. Krainc)

Moonlight Bio (J. Choi)

Nfold (S. Eisenbarth)

Oligo Foundry (E.M. McNally)

Omega Therapeutics (A. Shilatifard)

OrbiMed (D. Krainc)

PepGen (E.M. McNally)

Pfizer (N.S. Chandel, E.M. McNally)

Pyxis Oncology (M.L. Alegre)

Rafael Pharmaceuticals (N.S. Chandel)

Regeneron (J. Bass)

Riptide LLC (E.M. McNally)

Servier Laboratories (A.B. Heimberger)

Shanghai Henlius Biotech (Y. Yang)

Tenaya Therapeutics (E.M. McNally)

Thermo Fisher Scientific (J. Bass)

Three Squared Biosciences (E.B. Chang)

Vanqua Bio (D. Krainc)

Vertex Pharmaceuticals (J. Bass)

Visiongate LLC (A. Bharat)

Vortex Therapeutics (S.A. Abdulkadir)